Jurjen Tel
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 51
- Immunotherapy and Immune Responses 42
- T-cell and B-cell Immunology 28
- Immune Cell Function and Interaction 25
- Immune Response and Inflammation 7
- Oncology 22
- CAR-T cell therapy research 15
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Carl G. FigdorI. Jolanda M. de VriesGerty SchreibeltLuis J. CruzGosse J. AdemaJorieke WeidenLoek J. EggermontDaniel Benítez‐Ribas
- Journals
- Frontiers in Immunology (5 papers)The Journal of Immunology (4 papers)OncoImmunology (4 papers)Cancer Immunology Immunotherapy (4 papers)Frontiers in Bioengineering and Biotechnology (3 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Jurjen Tel
73 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 117
- Immunology 2.4k
- Oncology 1.1k
- Biomaterials 290
- Biomedical Engineering 865
- Pharmaceutical Science 117
Countries citing papers authored by Jurjen Tel
This map shows the geographic impact of Jurjen Tel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jurjen Tel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jurjen Tel more than expected).
Fields of papers citing papers by Jurjen Tel
This network shows the impact of papers produced by Jurjen Tel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jurjen Tel. The network helps show where Jurjen Tel may publish in the future.
Co-authors
The 25 scholars most cited alongside Jurjen Tel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 9 | |
| 3 | 2022 | 48 | |
| 4 | 2022 | 18 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 21 | |
| 7 | 2019 | 18 | |
| 8 | 2018 | 250 | |
| 9 | 2018 | 51 | |
| 10 | 2016 | 40 | |
| 11 | 2016 | 55 | |
| 12 | 2014 | 22 | |
| 13 | 2014 | 183 | |
| 14 | 2013 | 289 | |
| 15 | 2013 | 66 | |
| 16 | 2012 | 61 | |
| 17 | 2012 | 47 | |
| 18 | 2011 | 42 | |
| 19 | 2011 | 59 | |
| 20 | 2010 | 17 |
About Jurjen Tel
Jurjen Tel is a scholar working on Immunology, Oncology, Biomedical Engineering, Molecular Biology and Surfaces, Coatings and Films, having authored 73 papers that have together received 3.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (42 papers), T-cell and B-cell Immunology (28 papers), Immune Cell Function and Interaction (25 papers), CAR-T cell therapy research (15 papers), Innovative Microfluidic and Catalytic Techniques Innovation (10 papers), Immune Response and Inflammation (7 papers), Single-cell and spatial transcriptomics (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (1.1k citations), Biomaterials (290 citations), Biomedical Engineering (865 citations) and Pharmaceutical Science (117 citations). Jurjen Tel has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Carl G. Figdor, I. Jolanda M. de Vries, Gerty Schreibelt, Luis J. Cruz, Gosse J. Adema, Jorieke Weiden, Loek J. Eggermont, Daniel Benítez‐Ribas, Wilhelm T. S. Huck and Venkatachalam Chokkalingam. Their work appears in journals such as Frontiers in Immunology, The Journal of Immunology, OncoImmunology, Cancer Immunology Immunotherapy and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.